Ruman Rahman

2.1k total citations
81 papers, 1.4k citations indexed

About

Ruman Rahman is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Ruman Rahman has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 34 papers in Genetics and 24 papers in Biomedical Engineering. Recurrent topics in Ruman Rahman's work include Glioma Diagnosis and Treatment (34 papers), Nanoparticle-Based Drug Delivery (16 papers) and Nanoplatforms for cancer theranostics (12 papers). Ruman Rahman is often cited by papers focused on Glioma Diagnosis and Treatment (34 papers), Nanoparticle-Based Drug Delivery (16 papers) and Nanoplatforms for cancer theranostics (12 papers). Ruman Rahman collaborates with scholars based in United Kingdom, United States and France. Ruman Rahman's co-authors include Stuart Smith, Richard G. Grundy, Beth Coyle, James Lowe, Cheryl V. Rahman, Alessio Malfanti, Véronique Préat, John‐Paul Kilday, Chiara Bastiancich and Sara Dyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ruman Rahman

77 papers receiving 1.4k citations

Peers

Ruman Rahman
Toral Patel United States
Paula Schiapparelli United States
Mark C. de Gooijer Netherlands
Margarita Gutova United States
Becky Slagle‐Webb United States
Gene T. Yocum United States
Alex L. Tobias United States
Brenda Auffinger United States
Toral Patel United States
Ruman Rahman
Citations per year, relative to Ruman Rahman Ruman Rahman (= 1×) peers Toral Patel

Countries citing papers authored by Ruman Rahman

Since Specialization
Citations

This map shows the geographic impact of Ruman Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruman Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruman Rahman more than expected).

Fields of papers citing papers by Ruman Rahman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruman Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruman Rahman. The network helps show where Ruman Rahman may publish in the future.

Co-authorship network of co-authors of Ruman Rahman

This figure shows the co-authorship network connecting the top 25 collaborators of Ruman Rahman. A scholar is included among the top collaborators of Ruman Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruman Rahman. Ruman Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reimóndez-Troitiño, Sonia, Pablo Cabezas‐Sainz, María de la Fuente, et al.. (2025). Protamine-Based Nanotherapeutics for Gene Delivery to Glioblastoma Cells. Molecular Pharmaceutics. 22(5). 2466–2481. 3 indexed citations
2.
Cavanagh, Robert, Patricia Monteiro, Vincenzo Taresco, et al.. (2024). Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models. Biomaterials Science. 12(7). 1822–1840. 5 indexed citations
3.
Jain, Akhil, Haowei Wang, Sajib Chakraborty, et al.. (2024). EXTH-61. TOWARDS A QUANTUM THERAPY FOR GLIOBLASTOMA: A NEW THERAPEUTIC PARADIGM IN MEDICINE. Neuro-Oncology. 26(Supplement_8). viii250–viii250.
4.
Rahman, Ruman, et al.. (2024). Bipolar electrochemical growth of conductive microwires for cancer spheroid integration: a step forward in conductive biological circuitry. Scientific Reports. 14(1). 21012–21012. 1 indexed citations
5.
Cavanagh, Robert, Asmaa Ibrahim, Amanda K. Pearce, et al.. (2023). Chain-extension in hyperbranched polymers alters tissue distribution and cytotoxicity profiles in orthotopic models of triple negative breast cancers. Biomaterials Science. 11(19). 6545–6560. 1 indexed citations
6.
Needham, David, et al.. (2023). Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery. Pharmaceutics. 15(2). 599–599. 4 indexed citations
7.
Paine, Simon, et al.. (2023). Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS. Analytical Chemistry. 95(14). 5994–6001. 19 indexed citations
8.
Andrieux, Geoffroy, Jakob Straehle, Simon Paine, et al.. (2023). Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence. Genome Medicine. 15(1). 48–48. 23 indexed citations
9.
Jain, Akhil, Shao-Chuang Liu, Haowei Wang, et al.. (2023). Wireless electrical–molecular quantum signalling for cancer cell apoptosis. Nature Nanotechnology. 19(1). 106–114. 35 indexed citations
10.
Cavanagh, Robert, et al.. (2023). PRO-DRUG NANOPARTICLES AS SYNERGISTIC DRUG COMBINATION CARRIERS FOR IDH1-WT GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_3). iii1–iii1. 1 indexed citations
11.
Abdelrazig, Salah, Catherine A. Ortori, Sean May, et al.. (2022). Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism. Cancers. 14(16). 3873–3873. 3 indexed citations
12.
Castellanos, Marcos, et al.. (2021). CG7379 and ING1 suppress cancer cell invasion by maintaining cell–cell junction integrity. Open Biology. 11(9). 210077–210077. 2 indexed citations
16.
Smith, Stuart, et al.. (2020). Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma. Journal of Controlled Release. 328. 917–931. 32 indexed citations
17.
Smith, Stuart, Betty Tyler, Gareth J. Veal, et al.. (2019). Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste. Clinical Cancer Research. 25(16). 5094–5106. 40 indexed citations
18.
Rahman, Ruman & Richard G. Grundy. (2011). Histone deacetylase inhibition as an anticancer telomerase‐targeting strategy. International Journal of Cancer. 129(12). 2765–2774. 18 indexed citations
19.
Rahman, Ruman, Teresa Osteso-Ibáñez, Robert A. Hirst, et al.. (2010). Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells. Molecular Cancer Therapeutics. 9(9). 2568–2581. 31 indexed citations
20.
Rahman, Ruman, et al.. (2006). Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth. Biochemical and Biophysical Research Communications. 350(3). 796–802. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026